Authors
Latest:
AAOpt 2024: What optometrists think of the NutriTears supplement so farNeda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been recommending the NutriTears supplement to their dry eye patients.
Latest:
Transcript: Visus presbyopia drop gets FDA IND OKA presbyopia-correcting eyedrop recently received FDA acceptance of its investigational new drug (IND) application
Latest:
Lessons learned from COVID-19: How to prepare for the next public health emergencyHow eye care practices and doctors can prepare for the next pandemic
Latest:
Telehealth success hinges on better toolsAs the need for telemedicine increases, so does the urgency for creating new, less intrusive technology platforms.
Latest:
AAOpt 2022: The importance of perioperative management in corneal crosslinkingChris Kenrick, OD, shares what she finds to be most important from her discussion this year at AAOpt 2022.
Latest:
SCOPA 2022: Low vision considerations, treatments, and toolsJamie Ho, OD, FAAO, FCOVD, shares highlights from her SCOPA 2022 presentation, "Tools and considerations for low vision rehabilitation."
Latest:
NOA 2023: Dissecting the state of optometryEssence Johnson, OD, FAAO, addressed the "State of optometry," at NOA 2023 in Fort Lauderdale, Florida.
Latest:
Efficiency of physiotherapy in treating and preventing uncomplicated acquired myopiaAn inside look into a retrospective study conducted from 2019 to 2023 that aimed to assess the effectiveness of treatment and prevention of the progression of uncomplicated acquired myopia through physiotherapeutic methods.
Latest:
What the COVID-19 pandemic may mean for the power of electronic health recordsElectronic health records may be the future of practice management.
Latest:
Agent improves near vision for irregular corneas with pinhole effectPresbyopia-correcting drops for patients with low, up-close visual function.
Latest:
A roundup of legislative news from 2025 so farWhat to know about legislative moves that have been made through May this year.
Latest:
How diabetes and glaucoma intersectConsider the impact of diabetes on management of patients with glaucoma
Latest:
Pipeline: New therapies to come for debilitating eye diseasesNew drug from Gensight Biologics hits pipeline
Latest:
Shared care of the ocular surface before and after cataract surgeryPractices must efficiently integrate optometry and ophthalmology, delegating appropriate care to the proper specialist, in order to ensure patients’ total eye care needs are best met.
Latest:
The Impressions and Takeaways from Patient Case No. 2An expert underscores the importance of a comprehensive dry eye examination and offers insights on distinguishing it from neurotrophic keratitis.
Latest:
The white cane and beyond: Part 2Navigation and orientation technologies offer practical solution for people with vision loss.
Latest:
AAOpt 2022: A collaborative approach to pediatric keratoconus offers positive patient outcomesChristina Twardowski, OD, FAAO, and Erin D. Stahl, MD, share highlights from their discussion titled, "A collaborative approach to pediatric keratoconus," which they presented during the 2022 American Academy of Optometry meeting.
Latest:
Nerve growth factor: From discovery to development for human useThe evolution opens doors for the treatment of neurotrophic keratitis and beyond.
Latest:
ASCRS 2023: Laser scleral microporation from Ace Vision GroupMitchell Jackson, MD, discussed laser scleral microporation from Ace Vision Group at the 2023 ASCRS annual meeting in San Diego.
Latest:
Vision Expo: Q&A with Vision Council CEO Ashley Mills on big changes coming to the meetingAshley Mills, CEO of The Vision Council, gives insight into the decision to move to a flagship annual meeting and shares the vision for the meeting going forward.
Latest:
Getting started: methods of initial scleral lens selectionConsider 2 approaches when fitting patients.
Latest:
Brainstorming eye care research expansion with unlimited resourcesFrom contact lens dropout to addressing diabetic retinopathy in rural communities, optometrists choose an area of eye care research that they would expand, given the appropriate resources.
Latest:
EyePoint completes enrollment of LUGANO and LUCIA trialsEyePoint Pharmaceuticals completes enrollment for the LUCIA trial, advancing DURAVYU's potential as a new treatment for wet AMD.
Latest:
Sight Sciences releases cost-utility analysis comparing TearCare and cyclosporine 0.05% in dry eyeTearCare is associated with greater health utility over time but also resulted in significant cost savings compared with CsA.
Latest:
CCS 2025: Minimizing risk in comanagement as an eye care providerLori Wright, JD, sat down to talk about a presentation at Collaborative Care Symposium about the risk under federal statutes and how to minimize that risk as an optometrist or an ophthalmic practice.
Latest:
Seeing patients eye to eyeHonest discussions about treatments for dry eye disease can enhance compliance and simplify care.
Latest:
Pregnancy and postpartum ophthalmic changes can present a challengeSerious pathologies require high index of suspicion for diagnosis, management
